Full text is available at the source.
The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass
The long-lasting VIP-like drug RO 25-1553 targets the VIP2 receptor subtype
AI simplified
Abstract
RO 25-1553 is threefold more potent than VIP on the human VIP2 receptor.
- RO 25-1553 induced relaxation of tracheal and bronchial smooth muscles.
- It reduced edema and eosinophilic mobilization during pulmonary anaphylaxis.
- The compound acted as a full agonist on the VIP2, PACAP I, and rat VIP1 receptors.
- It was a partial agonist on the human VIP1 receptor.
- RO 25-1553 displayed varying potency across different receptor subclasses.
AI simplified